Business & Tech
Malvern Company Seeks To Heal Warts: Report
There are no currently no prescription drugs which treat common warts that are approved by the FDA. Could Malvern host a huge breakthrough?
One Malvern could be getting close to a huge breakthrough.
Aclaris Therapeutics, headquartered on 101 Lindenwood Drive, has begun testing on a new therapy for common warts, a report states.
More than 100 patients will be enrolled in phase-II of clinical trials for A-101, a topical drug the company is developing, according to the report.
Find out what's happening in Malvernfor free with the latest updates from Patch.
“Studying A-101 in a second dermatological condition is an important milestone as we continue to expand our development pipeline,” Dr. Neal Walker, president and CEO of Aclaris, told the Philadelphia Business Journal.
About 1.9 million people are diagnosed with warts annually.
Find out what's happening in Malvernfor free with the latest updates from Patch.
There are no currently no prescription drugs which treat common warts that are approved by the FDA, the report states.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
